CXCL12 and neoplasm: Data clearly suggests that when SKG mice were induced to develop tumors, the level of SDF-1 significantly increased in the lungs and that treatment with anti-IL-17A antibody brought the levels back down to the non-tumor bearing levels (Figure 4A).